Epidemiology of microvascular complications of diabetes in South Asians and comparison with other ethnicities

Journal of Diabetes

Volumn 8, Issue 4, 2016, Pages 470-482

  Gupta, Ritesh ^a   Misra, Anoop ^a,b,c  

^a Fortis C DOC Center for Excellence for Diabetes Metabolic Diseases and Endocrinology   (India)

^b Obesity and Cholesterol Disorders Foundation   (India)

^c Diabetes Foundation India New Delhi   (India)

Author keywords

Asian Indians; complications; diabetes; microvascular; South Asians

Indexed keywords

CAUCASIAN; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; ETHNICITY; HUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOUTH ASIAN;

EID: 84973866286     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12378     Document Type: Review

References (120)

1. Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In: Gan D (ed). Diabetes Atlas, 3rd edn. Belgium, International Diabetes Federation, 2006; 15–103.
2. Mohan V, Shah S, Saboo B. Current glycemic status and diabetes related complications among type 2 diabetes patients in India: Data from the A1chieve study. J Assoc Physicians India. 2013; 61 (Suppl. 1): 12–5.
3. Gupta A, Gupta AK, Singh TP. Occurrence of complications in newly diagnosed type 2 diabetes patients: A hospital based study. J Indian Med Assoc. 2013; 111: 245–7.
4. Ali A, Iqbal F, Taj A, Iqbal Z, Amin MJ, Iqbal QZ. Prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes. Pak J Med Sci. 2013; 29: 899–902.
5. Tharkar S, Devarajan A, Kumpatla S, Viswanathan V. The socioeconomics of diabetes from a developing country: A population based cost of illness study. Diabetes Res ClinPract. 2010; 89: 334–40.
6. Kapur A Economic analysis of diabetes care. Indian J Med Res. 2007; 125: 473–82.
7. Bhardwaj S, Misra A, Misra R, et al. High prevalence of abdominal, intra-abdominal and subcutaneous adiposity and clustering of risk factors among urban Asian Indians in North India. PLoS One. 2011; 6: e24362.
8. Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int J Obes (Lond). 2011; 35: 167–87.
9. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008; 93 (11 Suppl. 1): S9–30.
10. Davis TM, Coleman RL, Holman RR; UKPDS Group. Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83). Diabet Med. 2014; 31: 200–7.
11. Agarwal SK, Srivastava RK. Chronic Kidney Disease in India: Challenges and solutions. Nephron Clin Pract. 2009; 111: c197–203.
12. Rajapurkar MM, John GT, Kirpalani AL, et al. What do we know about chronic kidney disease in India: First report of the Indian CKD registry. BMC Nephrol. 2012; 13: 10.
13. Wijewickrama ES, Weerasinghe D, Sumathipala PS, Horadagoda C, Lanarolle RD, Sheriff RM. Epidemiology of chronic kidney disease in a Sri Lankan population: Experience of a tertiary care center. Saudi J Kidney Dis Transpl. 2011; 22: 1289–93.
14. Dash SC, Agarwal SK. Incidence of chronic kidney disease in India. Nephrol Dial Transplant. 2006; 21: 232–3.
15. Modi GK, Jha V. The incidence of end-stage renal disease in India: A population-based study. Kidney Int. 2006; 70: 2131–3.
16. Singh NP, Ingle GK, Saini VK, et al. Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft–Gault and Modification of Diet in Renal Disease equation: An observational, cross-sectional study. BMC Nephrol. 2009; 10: 4.
17. Varma PP, Raman DK, Ramakrishnan TS, Singh P, Varma A. Prevalence of early stages of chronic kidney disease in apparently healthy central government employees in India. Nephrol Dial Transplant. 2010; 25: 3011–7.
18. Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study. Indian J Med Res. 2012; 136: 46–53.
19. Raman R, Gupta A, Krishna S, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. SankaraNethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). J Diabetes Complications. 2012; 26: 123–8.
20. Kumar HK, Kota S, Basile A, Modi K. Profile of microvascular disease in type 2 diabetes in a tertiary health care hospital in India. Ann Med Health Sci Res. 2012; 2: 103–8.
21. Rani PK, Raman R, Gupta A, Pal SS, Kulothungan V, Sharma T. Albuminuria and diabetic retinopathy in type 2 diabetes mellitus SankaraNethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 12). Diabetol Metab Syndr. 2011; 3: 9.
22. Amutha A, Datta M, Unnikrishnan IR, et al. Clinical profile of diabetes in the young seen between 1992 and 2009 at a specialist diabetes centre in south India. Prim Care Diabetes. 2011; 5: 223–9.
23. Agarwal N, Sengar NS, Jain PK, Khare R. Nephropathy in newly diagnosed type 2 diabetics with special stress on the role of hypertension. J Assoc Physicians India. 2011; 59: 145–7.
24. Kanakamani J, Ammini AC, Gupta N, Dwivedi SN. Prevalence of microalbuminuria among patients with type 2 diabetes mellitus: A hospital-based study from north India. Diabetes Technol Ther. 2010; 12: 161–6.
25. Potluri R, Purmah Y, Dowlut M, Sewpaul N, Lavu D. Microvascular diabetic complications are more prevalent in India compared to Mauritius and the UK due to poorer diabetic control. Diabetes Res ClinPract. 2009; 86: e39–40.
26. Unnikrishnan RI, Rema M, Pradeepa R, et al. Prevalence and risk factors of diabetic nephropathy in an urban south Indian population. Diabetes Care. 2007; 30: 2019–24.
27. Agrawal RP, Ranka M, Beniwal R, et al. Prevalence of micro and macro vascular complications in type 2 diabetes and their risk factors. Int J Diabetes Dev Ctries. 2004; 24: 11–6.
28. Varghese A, Deepa R, Rema M, Mohan V. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India. Postgrad Med J. 2001; 77: 399–402.
29. Viswanathan V, Chamukuttan S, Kuniyil S, Ambady R. Evaluation of a simple, random urine test for prospective analysis of proteinuria in Type 2 diabetes: A six year follow-up study. Diabetes Res Clin Pract. 2000; 49: 143–7.
30. Latif ZA, Jain A, Rahman MM. Evaluation of management, control, complications and psychosocial aspects of diabetics in Bangladesh: DiabCare Bangladesh 2008. Bangladesh Med Res Counc Bull. 2011; 37: 11–6.
31. Jha P, Das BK, Shrestha S, et al. Glycemic status, lipid profile and proteinuria in diabetic nephropathy. J Nepal Med Assoc. 2010; 49: 143–6.
32. Jafar TH, Qadri Z, Hashmi S. Prevalence of microalbuminuria and associated electrocardiographic abnormalities in an Indo-Asian population. Nephrol Dial Transplant. 2009; 24: 2111–6.
33. Sigdel M, Rajbhandari N, Basnet S, Nagila A, Basnet P, Tamrakar BK. Microalbuminuria among type-2 diabetes mellitus patients in Pokhara. Nepal Nepal Med Coll J. 2008; 10: 242–5.
34. Aryal M, Jha B. Assessment of proteinuria as a marker of nephropathy in type 2 diabetes mellitus. Nepal Med Coll J. 2006; 8: 250–3.
35. Ahmedani MY, Hydrie MZ, Iqbal A, Gul A, Mirza WB, Basit A. Prevalence of microalbuminuria in type 2 diabetic patients in Karachi, Pakistan: A multi-center study. J Pak Med Assoc. 2005; 55: 382–6.
36. Weerasuriya N, Siribaddana S, Dissanayake A, Subasinghe Z, Wariyapola D, Fernando DJ. Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus. Q J Med. 1998; 91: 439–43.
37. Gokulnath, Sahay M, Kalra S et al. Protocol of an observational study to evaluate diabetic nephropathy through detection of microalbuminuria in Indian patients. Indian J Endocrinol Metab. 2013; 17: 496–504.
38. Samanta A, Burden AC, Feehally J, Walls J. Diabetic renal disease: Differences between Asian and White patients. Br Med J (Clin Res Ed). 1986; 293: 366–7.
39. Mather HM, Chaturvedi N, Fuller JH. Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow- up of the Southall Diabetes Survey, London, UK. Diabet Med. 1998; 15: 53–9.
40. Chandie Shaw PK, Vandenbroucke JP, Tjandra YI, et al. Increased end-stage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands. Diabetologia. 2002; 45: 337–41.
41. Chandie Shaw PK, van Es LA, Paul LC, Rosendaal FR, Souverijn JH, Vandenbroucke JP. Renal disease in relatives of Indo-Asian Type 2 diabetic patients with end-stage diabetic nephropathy. Diabetologia. 2003; 46: 618–24.
42. Chandie Shaw PK, Baboe F, van Es LA, et al. South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch–European diabetic patients. Diabetes Care. 2006; 29: 1383–5.
43. Raymond NT, Paul O′Hare J, Bellary S, et al. Comparative risk of microalbuminuria and proteinuria in UK residents of south Asian and White European ethnic background with type 2 diabetes: A report from UKADS. Curr Med Res Opin. 2011; 27 (Suppl. 3):47–55.
44. Dreyer G, Hull S, Aitken Z, Chesser A, Yaqoob MM. The effect of ethnicity on the prevalence of diabetes and associated chronic kidney disease. Q J Med. 2009; 102: 261–9.
45. Dreyer G, Hull S, Mathur R, Chesser A, Yaqoob MM. Progression of chronic kidney disease in a multi-ethnic community cohort of patients with diabetes mellitus. Diabet Med. 2013; 30: 956–63.
46. Aryal M, Jha B. Assessment of proteinuria as a marker of nephropathy in type 2 diabetes mellitus. Nepal Med Coll J. 2006; 8: 250–3.
47. Bhalla V, Zhao B, Azar KM, et al. Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care. 2013; 36: 1215–21.
48. Kanaya AM, Adler N, Moffet HH, et al. Heterogeneity of diabetes outcomes among Asians and Pacific Islanders in the US: The diabetes study of Northern California (DISTANCE). Diabetes Care. 2011; 34: 930–7.
49. Ali O, Mohiuddin A, Mathur R, Dreyer G, Hull S, Yaqoob MM. A cohort study on the rate of progression of diabetic chronic kidney disease in different ethnic groups. BMJ Open. 2013; 3: 2.
50. Bennett PH, Lee ET, Lu M, Keen H, Fuller JH. Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001; 44 (Suppl. 2): S37–45.
51. Sabanayagam C, Lim SC, Wong TY, Lee J, Shankar A, Tai ES. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease. Nephrol Dial Transplant. 2010; 25: 2564–70.
52. Hong CY, Chia KS, Hughes K, Ling SL. Ethnic differences among Chinese, Malay and Indian patients with type 2 diabetes mellitus in Singapore. Singapore Med J. 2004; 45: 154–60.
53. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012; 96: 614–8.
54. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82: 844–51.
55. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984; 102: 520–6.
56. Rajalakshmi R, Amutha A, Ranjani H, et al. Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset Type 1 and Type 2 Diabetes. J Diabetes Complications. 2014; 28: 291–7.
57. Katulanda P, Waniganayake YC, Ranasinghe P, et al. Retinopathy among young adults with diabetes mellitus from a tertiary care setting in Sri Lanka. BMC Endocr Disord. 2014; 14: 20.
58. Raman R, Gupta A, Krishna S, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed Type II diabetes mellitus. SankaraNethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). J Diabetes Complications. 2012; 26: 123–8.
59. Das AK, Seshiah V, Sahay BK, et al. Improving management practices and clinical outcomes in type 2 diabetes study: Prevalence of complications in people with type 2 diabetes in India. Indian J Endocrinol Metab. 2012; 16(Suppl. 2):S430–1.
60. Vaz NC, Ferreira A, Kulkarni M, Vaz FS, Pinto N. Prevalence of diabetic complications in rural Goa. India Indian J Community Med. 2011; 36: 283–6.
61. Vyas U, Khandekar R, Trivedi N, Desai T, Danayak P. Magnitude and determinants of ocular morbidities among persons with diabetes in a project in Ahmedabad. India Diabetes Technol Ther. 2009; 11: 601–7.
62. Namperumalsamy P, Kim R, Vignesh TP, et al. Prevalence and risk factors for diabetic retinopathy: A population-based assessment from Theni District, south India. Postgrad Med J. 2009; 85: 643–8.
63. Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med. 2009; 55: 92–6.
64. Raman R, Rani PK, Kulothungan V, Rachepalle SR, Kumaramanickavel G, Sharma T. Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SankaraNethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study report number 13. Ophthalmology. 2010; 117: 766–72.
65. Krishnaiah S, Das T, Nirmalan PK, et al. Risk factors for diabetic retinopathy: Findings from The Andhra Pradesh Eye Disease Study. Clin Ophthalmol. 2007; 1: 475–82.
66. Rani PK, Raman R, Sharma V, et al. Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries. Br J Ophthalmol. 2007; 91: 1425–9.
67. Agarwal S, Raman R, Kumari RP, et al. Diabetic retinopathy in Type II diabetics detected by targeted screening versus newly diagnosed in general practice. Ann Acad Med Singapore. 2006; 35: 531–5.
68. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I. Invest Ophthalmol Vis Sci. 2005; 46: 2328–33.
69. Sunita M, Desai S, Vinay P, et al. Aditya Jyot-Diabetic Retinopathy in Urban Mumbai Slums Study (AJ-DRUMSS): Study design and methodology, report 1. Ophthalmic Epidemiol. 2014; 21: 51–60.
70. Shera AS, Jawad F, Maqsood A, Jamal S, Azfar M, Ahmed U. Prevalence of chronic complications and associated factors in type 2 diabetes. J Pak Med Assoc. 2004; 54: 54–9.
71. Afghani T, Qureshi N, Chaudhry KS. Screening for diabetic retinopathy: A comparative study between hospital and community based screening and between paying and non-paying patients. J Ayub Med Coll Abbottabad. 2007; 19: 16–22.
72. Hussain S, Qamar MR, Iqbal MA, Ahmad A, Ullah E. Risk factors of retinopathy in type 2 diabetes mellitus at a tertiary care hospital. Bahawalpur Pakistan Pak J Med Sci. 2013; 29: 536–9.
73. Shrestha MK, Paudyal G, Wagle RR, Gurung R, Ruit S, Onta SR. Prevalence of and factors associated with diabetic retinopathy among diabetics in Nepal: A hospital based study. Nepal Med Coll J. 2007; 9: 225–9.
74. Paudyal G, Shrestha MK, Meyer JJ, Thapa R, Gurung R, Ruit S. Prevalence of diabetic retinopathy following a community screening for diabetes. Nepal Med Coll J. 2008; 10: 160–3.
75. Akhter A, Fatema K, Ahmed SF, Afroz A, Ali L, Hussain A. Prevalence and associated risk indicators of retinopathy in a rural Bangladeshi population with and without diabetes. Ophthalmic Epidemiol. 2013; 20: 220–7.
76. Sivaprasad S, Gupta B, Gulliford MC, et al. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PLoS One. 2012; 7: e32182.
77. Gupta B, Sivaprasad S, Wong R, et al. Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: The DRIVE UK study. Eye (Lond). 2012; 26: 510–6.
78. Raymond NT, Varadhan L, Reynold DR, et al. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with White Europeans in the community: A cross-sectional study. Diabetes Care. 2009; 32: 410–5.
79. Pardhan S, Gilchrist J, Mahomed I. Impact of age and duration on sight-threatening retinopathy in South Asians and Caucasians attending a diabetic clinic. Eye. 2004; 18: 233–40.
80. Stolk RP, van Schooneveld MJ, Cruickshank JK, et al. Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: Baseline results from the ADVANCE Retinal Measurements (AdRem) study. Diabetes Care. 2008; 31: 708–13.
81. Thomas RL, Distiller L, Luzio SD, et al. Ethnic differences in the prevalence of diabetic retinopathy in persons with diabetes when first presenting at a diabetes clinic in South Africa. Diabetes Care. 2013; 36: 336–41.
82. Forster AS, Forbes A, Dodhia H, et al. Changes in detection of retinopathy in Type 2 diabetes in the first 4 years of a population-based diabetes eye screening program: Retrospective cohort study. Diabetes Care. 2013; 36: 2663–9.
83. Chiang PP, Lamoureux EL, Cheung CY, et al. Racial differences in the prevalence of diabetes but not diabetic retinopathy in a multi-ethnic Asian population. Invest Ophthalmol Vis Sci. 2011; 52: 7586–92.
84. Zheng Y, Lamoureux EL, Ikram MK, et al. Impact of migration and acculturation on prevalence of type 2 diabetes and related eye complications in Indians living in a newly urbanised society. PLoS One. 2012; 7: e34829.
85. IndINeP Study Group. Burden of neuropathic pain in Indian patients attending urban, specialty clinics: Results from a cross sectional study. Pain Pract. 2008; 8: 362–78.
86. Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med. 2008; 25: 407–12.
87. Jayaprakash P, Bhansali S, Bhansali A, Dutta P, Anantharaman R. Magnitude of foot problems in diabetes in the developing world: A study of 1044 patients. Diabet Med. 2009; 26: 939–42.
88. Martin CL, Waberski BH, Pop-Busui R, et al. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: Results from the DCCT/EDIC study. Diabetes Care. 2010; 33: 2635–41.
89. Ghosal S, Stephens J, Mukherjee A. Quantitative vibration perception threshold in assessing diabetic neuropathy: Is the cut-off value lower for Indian subjects? [Q-VADIS Study]. Diabetes MetabSyndr. 2012; 6: 85–9.
90. Jayaprakash P, Bhansali A, Bhansali S, et al. Validation of bedside methods in evaluation of diabetic peripheral neuropathy. Indian J Med Res. 2011; 133: 645–9.
91. Sriyani KA1, Wasalathanthri S, Hettiarachchi P, Prathapan S. Predictors of diabetic foot and leg ulcers in a developing country with a rapid increase in the prevalence of diabetes mellitus. PLoS One. 2013; 8: e80856.
92. Rani PK, Raman R, Rachapalli SR, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for severity of diabetic neuropathy in type 2 diabetes mellitus. Indian J Med Sci. 2010; 64: 51–7.
93. Mørkrid K, Ali L, Hussain A. Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh. Int J Diabetes Dev Ctries. 2010; 30: 11–7.
94. Shera AS, Jawad F, Maqsood A, Jamal S, Azfar M, Ahmed U. Prevalence of chronic complications and associated factors in type 2 diabetes. J Pak Med Assoc. 2004; 54: 54–9.
95. Ashok S, Ramu M, Deepa R, Mohan V. Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India. 2002; 50: 546–50.
96. Ramachandran A, Snehalatha C, Satyavani K, Latha E, Sasikala R, Vijay V. Prevalence of vascular complications and their risk factors in type 2 diabetes. J Assoc Physicians India. 1999; 47: 1152–6.
97. Mohan V, Vijayaprabha R, Rema M. Vascular complications in long-term south Indian NIDDM of over 25 years' duration. Diabetes Res Clin Pract. 1996; 31: 133–40.
98. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study XII: Differences between Asian, Afro-Caribbean and White Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med. 1994; 11: 670–7.
99. Winkley K, Thomas SM, Sivaprasad S, et al. The clinical characteristics at diagnosis of type 2 diabetes in a multi-ethnic population: The South London Diabetes cohort (SOUL-D). Diabetologia. 2013; 56: 1272–81.
100. Abbott CA, Chaturvedi N, Malik RA, et al. Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans. Diabetes Care. 2010; 33: 1325–30.
101. Kote GS, Bhat AN, Thajuddeen K, Ismail MH, Gupta A. Peripheral insensate neuropathy: Is height a risk factor? J Clin Diagn Res. 2013; 7: 296–301.
102. Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff MH, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr. 2012; 4: 21.
103. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011; 34: 2220–4.
104. 12 deficiency and hyperhomocysteinemia in rural and urban Indians. J Assoc Physicians India. 2006; 54: 775–82.
105. 12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients. J Postgrad Med. 2013; 59: 253–7.
106. Nayak UB, Acharya V, Jain H, Lenka S. Clinical assessment of the autonomic nervous system in diabetes mellitus and its correlation with glycemic control. Indian J Med Sci. 2013; 67: 13–22.
107. Nanaiah A, Chowdhury SD, Jeyaraman K, Thomas N. Prevalence of cardiac autonomic neuropathy in Asian Indian patients with fibrocalculous pancreatic diabetes. Indian J Endocrinol Metab. 2012; 16: 749–53.
108. Khandelwal E, Jaryal AK, Deepak KK. Pattern and prevalence of cardiovascular autonomic neuropathy in diabetics visiting a tertiary care referral center in India. Indian J Physiol Pharmacol. 2011; 55: 119–27.
109. Jyotsna VP, Sahoo A, Sreenivas V, Deepak KK. Prevalence and pattern of cardiac autonomic dysfunction in newly detected type 2 diabetes mellitus. Diabetes Res Clin Pract. 2009; 83: 83–8.
110. Khoharo HK, Ansari S, Ali Shaikh I, Qureshi F. Cardiac autonomic neuropathy (CAN) in type-1 diabetes mellitus patients and its association with the duration of disease and glycemic control. J Coll Physicians Surg Pak. 2009; 19: 232–5.
111. Khoharo HK, Qureshi F. Frequency of cardiac autonomic neuropathy in patients with type 2 diabetes mellitus reporting at a teaching hospital of Sindh. J Coll Physicians Surg Pak. 2008; 18: 751–4.
112. Pappachan JM, Sebastian J, Bino BC, et al. Cardiac autonomic neuropathy in diabetes mellitus: Prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad Med J. 2008; 84: 205–10.
113. Mehta S, Mathur D, Chaturvedi M, Verma K. Incidence of cardiac autonomic neuropathy and its correlation with retinopathy, micro-albuminuria and glycated haemoglobin in non-insulin dependent diabetes mellitus. J Indian Med Assoc. 2002; 100: 141–3 152.
114. Jalal S, Alai MS, Khan KA, et al. Silent myocardial ischemia and cardiac autonomic neuropathy in diabetics. J Assoc Physicians India. 1999; 47: 767–9.
115. Viswanathan V, Prasad D, Chamukuttan S, Ramachandran A. High prevalence and early onset of cardiac autonomic neuropathy among South Indian type 2 diabetic patients with nephropathy. Diabetes Res Clin Pract. 2000; 48: 211–6.
116. Bathula R, Hughes AD, Panerai R, et al. Indian Asians have poorer cardiovascular autonomic function than Europeans: This is due to greater hyperglycaemia and may contribute to their greater risk of heart disease. Diabetologia. 2010; 53: 2120–8.
117. Laway BA, Malik TS, Khan SH, Rather TA. Prevalence of abnormal gastric emptying in asymptomatic women with newly detected diabetes and its reversibility after glycemic control: A prospective case control study. J Diabetes Complications. 2013; 27: 78–81.
118. Dutta U, Padhy AK, Ahuja V, Sharma MP. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics. Trop Gastroenterol. 1999; 20: 116–9.
119. Rana S, Bhansali A, Bhadada S, Sharma S, Kaur J, Singh K. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India. Diabetes Technol Ther. 2011; 13: 1115–20.
120. Gaur C, Mathur A, Agarwal A, Verma K, Jain R, Swaroop A. Diabetic autonomic neuropathy causing gall bladder dysfunction. J Assoc Physicians India. 2000; 48: 603–5.